Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
DOLCTH
Dolcetto Holdco SpA (Doc Pharma)€990
2EMEA
Jun 25, 2025
currency
EUR
size (m)
590.000
maturity
Jul 14, 2032
type
Fixed
tenor
7.000
call
3.00
registration
144A/Reg S
benchmark
-
ranking
Sr. Secured
moody's
B3
s&p
B
fitch
-
size description
-
re-open/tap
No
ipt
high 5s-6%
ipt-pxd
-
guidance
5.75% area (+/- 12.5bp); revised 5.625%-5.75%
spread
331
coupon
5.625%
spread set
-
price
100.00000
yield
5.625%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
currency
EUR
size (m)
400.000
maturity
Jul 14, 2032
type
Floating
tenor
7.000
call
1.00
registration
144A/Reg S
benchmark
-
ranking
Sr. Secured
moody's
B3
s&p
B
fitch
-
size description
-
re-open/tap
No
ipt
3mE+400bp area at par
ipt-pxd
-
guidance
E+375-400bp at par; Revised E+375bp area at par
spread
362.5
coupon
-
spread set
-
price
100.00000
yield
3mE+362.5bp
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
Redemption: 2028-06-25; Registration: 144A/Reg S; Redemption: 2026-06-25; Registration: 144A/Reg S;
Deal Comments
Dolcetto Holdco SpA (DOC Pharma) (DOLCTH) EUR990m 144A/Reg S sr sec notes 2-part. B3/B (stable/stable). Via BNP (B&D)/Barc jt glocos/DB jt physical books/IMI/Mizuho/CA/KKR jt books. No reg rights. List Lux. NY law. Settles 07/14. - EUR590m (from EUR350m minimum) sr sec fixed-rate notes due 07/14/32 (7y). NC3 (06/25/28) (MWC B+50bp), then at 102.813, 101.406, 100. Equity claw: 3y 40% at 105.625. IPO claw: 4y 50% at 101. Special call: 10% per year the first 3 years at 103. CoC at 101. 30/360. Pays March 15 and Sept 15, starting 09/15/25 (30/360). Denoms: 100x1. Reg S ISIN: XS3106724241. IPT: high 5s-6%. Price talk: 5.75% area (+/- 12.5bp). Revised price talk: 5.625%-5.75%. Priced: 5.625% at 100. +331bp vs DBR 1.70% 08/15/32. - EUR400m (from EUR350m minimum) sr sec FRN due 07/14/32 (7y). NC1 (06/25/26) (MWC B+50bp), then at 100. CoC at 101. Pays March 15, June 15, Sept 15 and Dec 15, starting 09/15/25 (Actual/360). Denoms: 100x1. Reg S ISIN: XS73106723516. IPT: 3mE+400bp area at par. Price talk: E+375-400bp at par. Revised price talk: E+375bp area at par. Priced: 3mE+362.5bp at 100. Roadshow (1-on-1s) 06/23-25 (investor call at 1pm UKT 06/30). Books closed at 4:30pm UKT (from 3pm UKT) 06/25. UOP: repay $973m unitranche facility, GCP. Equity sponsors: TPG (804%), ICG (17.9%). Biz: leading Italian generic pharmaceutical company. Deal roadshow: https://dealroadshow.com/ Entry code: DOC25.

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow